Please ensure Javascript is enabled for purposes of website accessibility

Is Moderna the Tesla of Bio Pharmaceuticals?

By Keith Speights and Adria Cimino – Updated Oct 1, 2021 at 9:16AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Now a household name through its mRNA Covid-19 vaccine, is Moderna stock set to move higher?

Keith Speights: Someone had commented that Moderna (MRNA -0.46%) was the Tesla (TSLA -1.46%) of BioTech. What do you think? You agree? Is Moderna the Tesla of BioTech? Both from a positive and the negative side. [laughs]

Adria Cimino: Yeah, I think that it really is because I think that everyone is very excited about Moderna. The CEO, Stéphane Bancel, he might not be in the style of Elon Musk, but he is out there always communicating and he's talking about the next thing that's going on. You really feel that there's a lot of excitement there, that they're always innovating, and I think Moderna can continue to gain, but I do think that it's been faster than what I would have predicted. I think I would have seen the gains but in a slower pace. So yeah, it really has gone faster and further than what we could've imagined I think.

Keith Speights: For Moderna, everything hinges on exceptionally strong COVID-19 vaccine sales for the next several years. Because it's going to take a little while before the company has any other pipeline candidates to be able to come to market. If those vaccine sales taper off, that stock is going to fall a lot. If this vaccine sales hold up, then as Moderna gets more pipeline candidates closer to approval then you could see it continue to generate some gains. That will be a fun one to watch, like Tesla, fun one to watch.

Adria Cimino: Yeah, I think so too.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Tesla. The Motley Fool recommends Moderna Inc. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Tesla Stock Quote
Tesla
TSLA
$180.25 (-1.46%) $-2.67
Moderna Inc. Stock Quote
Moderna Inc.
MRNA
$174.57 (-0.46%) $0.81

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
351%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.